Get started
Author

Yusuke Uchinami

Observed names: Uchinami, Yusuke, Y. Uchinami
ORCID: 0000-0001-5404-6109
Observed ORCID: 0000-0001-5404-6109
OpenAlex ID: A5032672925
Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan
2023 · Masashi Mizumoto, Hiroyuki Ogino, et al. · International Journal of Radiation Oncology*Biology*Physics · 38
PDF
Impact of organ motion on volumetric and dosimetric parameters in stomach lymphomas treated with intensity‐modulated radiotherapy
2019 · Yusuke Uchinami, Ryusuke Suzuki, et al. · Journal of Applied Clinical Medical Physics · 23
Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa
2016 · Yusuke Uchinami, Miyako Myojin, et al. · Radiation Oncology · 23
PDF
Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis
2018 · Norio Katoh, Hiroshi Onishi, et al. · Technology in Cancer Research & Treatment · 19
PDF
Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
2017 · Norio Katoh, Itaru Soda, et al. · Radiation Oncology · 17
PDF
Deformed dose restoration to account for tumor deformation and position changes for adaptive proton therapy
2022 · Koichi Miyazaki, Yusuke Fujii, et al. · Medical Physics · 16
Treatment outcomes of stereotactic body radiation therapy using a real‐time tumor‐tracking radiotherapy system for hepatocellular carcinomas
2021 · Yusuke Uchinami, Norio Katoh, et al. · Hepatology Research · 15
PDF
Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer
2023 · Yusuke Uchinami, Takahiro Kanehira, et al. · Clinical and Translational Radiation Oncology · 12
3‐Methylcholanthrene‐induced transforming growth factor‐β‐producing carcinomas, but not sarcomas, are refractory to regulatory T cell‐depletion therapy
2009 · Kenji Chamoto, Daiko Wakita, et al. · Cancer Science · 10
PDF
The need of radiotherapy optimization for glioblastomas considering immune responses
2023 · Kentaro Nishioka, Shuhei Takahashi, et al. · Japanese Journal of Radiology · 9
PDF
Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma
2023 · Yusuke Uchinami, Koichi Yasuda, et al. · Discover Oncology · 8
PDF
Proton Beam Therapy for Intrahepatic Cholangiocarcinoma: A Multicenter Prospective Registry Study in Japan
2023 · Masashi Mizumoto, Kazuki Terashima, et al. · Liver Cancer · 8
Analysis of particle therapy registries based on a unified treatment policy for esophageal cancer
2023 · Sunao Tokumaru, Hitoshi Ishikawa, et al. · Journal of Radiation Research · 8
PDF
Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy
2023 · Nayuta Tsushima, Satoshi Kano, et al. · International Journal of Clinical Oncology · 6
PDF
Effectiveness of CT‐image guidance in proton therapy for liver cancer and the importance of daily dose monitoring for tumors and organs at risk
2023 · Yoshikazu Maeda, Keiji Kobashi, et al. · Medical Physics · 6
Optimal resection area for superior mesenteric artery nerve plexuses after neoadjuvant chemoradiotherapy for locally advanced pancreatic carcinoma
2018 · Takahiro Einama, Hirofumi Kamachi, et al. · Medicine · 6
Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan
2023 · Koichi Yasuda, Yusuke Uchinami, et al. · International Journal of Clinical Oncology · 5
PDF
Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non–small‐cell lung cancer ( NEJ056 )
2024 · Megumi Furuta, Hidehito Horinouchi, et al. · Cancer Science · 4
PDF
A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity
2022 · Yusuke Uchinami, Norio Katoh, et al. · Clinical and Translational Radiation Oncology · 4
PDF
Patterns of Care for Brain Metastases in Asia: A Real-World Survey Conducted by the Federation of Asian Organizations for Radiation Oncology
2024 · Yusuke Uchinami, Archya Dasgupta, et al. · JCO Global Oncology · 3
PDF
Application of motion prediction based on a long short-term memory network for imaging dose reduction in real-time tumor-tracking radiation therapy
2024 · Kazuki Numakura, Seishin Takao, et al. · Physica Medica · 3
Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy
2024 · Yusuke Uchinami, Koichi Yasuda, et al. · Radiation Oncology Journal · 3
PDF
A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer
2024 · Kentaro Nishioka, Takayuki Hashimoto, et al. · Advances in Radiation Oncology · 3
PDF
The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma
2023 · Satoshi Kano, Takayoshi Suzuki, et al. · International Journal of Clinical Oncology · 3
Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors—retrospective study
2023 · Hajime Higaki, Kentaro Nishioka, et al. · Radiation Oncology · 3
Works count: 67
Citation count: 268
H-index: 9
I10-index: 9
Year
Topic
Type